These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 31726199)

  • 21. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
    Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
    J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
    Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
    Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.
    Lee TJ; Yoo JY; Shu D; Li H; Zhang J; Yu JG; Jaime-Ramirez AC; Acunzo M; Romano G; Cui R; Sun HL; Luo Z; Old M; Kaur B; Guo P; Croce CM
    Mol Ther; 2017 Jul; 25(7):1544-1555. PubMed ID: 28109960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.
    Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y
    EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
    Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
    Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis.
    Yang CH; Wang Y; Sims M; Cai C; He P; Yue J; Cheng J; Boop FA; Pfeffer SR; Pfeffer LM
    Oncotarget; 2016 Dec; 7(51):84017-84029. PubMed ID: 27705947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis.
    Rezaei T; Hejazi M; Mansoori B; Mohammadi A; Amini M; Mosafer J; Rezaei S; Mokhtarzadeh A; Baradaran B
    Eur J Pharmacol; 2020 Dec; 888():173483. PubMed ID: 32810491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel protein encoded by circCOPA inhibits the malignant phenotype of glioblastoma cells and increases their sensitivity to temozolomide by disrupting the NONO-SFPQ complex.
    Peng D; Wei C; Jing B; Yu R; Zhang Z; Han L
    Cell Death Dis; 2024 Aug; 15(8):616. PubMed ID: 39183343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative Proteomic Profiling of Tachyplesin I Targets in U251 Gliomaspheres.
    Li X; Dai J; Tang Y; Li L; Jin G
    Mar Drugs; 2017 Jan; 15(1):. PubMed ID: 28106765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.
    Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z
    Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
    Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
    Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy.
    Shatsberg Z; Zhang X; Ofek P; Malhotra S; Krivitsky A; Scomparin A; Tiram G; Calderón M; Haag R; Satchi-Fainaro R
    J Control Release; 2016 Oct; 239():159-68. PubMed ID: 27569663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Evaluation of Glioblastoma Cell Dissociation and Its Influence on Its Behavior.
    Skarkova V; Krupova M; Vitovcova B; Skarka A; Kasparova P; Krupa P; Kralova V; Rudolf E
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin treatment reduces temozolomide resistance of glioblastoma cells.
    Yang SH; Li S; Lu G; Xue H; Kim DH; Zhu JJ; Liu Y
    Oncotarget; 2016 Nov; 7(48):78787-78803. PubMed ID: 27791206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of PTPRS elicits potent metastatic capability and resistance to temozolomide in glioblastoma.
    Zhang Y; Chang L; Huang P; Cao M; Hong R; Zhao X; He X; Xu L
    Mol Carcinog; 2024 Jul; 63(7):1235-1247. PubMed ID: 38517048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C1q/TNF-related peptide 8 (CTRP8) promotes temozolomide resistance in human glioblastoma.
    Thanasupawat T; Glogowska A; Burg M; Krcek J; Beiko J; Pitz M; Zhang GJ; Hombach-Klonisch S; Klonisch T
    Mol Oncol; 2018 Sep; 12(9):1464-1479. PubMed ID: 29949238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticle-Delivered Antisense MicroRNA-21 Enhances the Effects of Temozolomide on Glioblastoma Cells.
    Ananta JS; Paulmurugan R; Massoud TF
    Mol Pharm; 2015 Dec; 12(12):4509-17. PubMed ID: 26559642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of MDR1 by Ad-DKK3 via Akt/NFκB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model.
    Fujihara T; Mizobuchi Y; Nakajima K; Kageji T; Matsuzaki K; Kitazato KT; Otsuka R; Hara K; Mure H; Okazaki T; Kuwayama K; Nagahiro S; Takagi Y
    J Neurooncol; 2018 Sep; 139(2):323-332. PubMed ID: 29779087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.
    Chen PH; Cheng CH; Shih CM; Ho KH; Lin CW; Lee CC; Liu AJ; Chang CK; Chen KC
    PLoS One; 2016; 11(11):e0167096. PubMed ID: 27893811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression.
    Wei J; Qi X; Zhan Q; Zhou D; Yan Q; Wang Y; Mo L; Wan Y; Xie D; Xie J; Yang S
    Biomed Pharmacother; 2015 Apr; 71():112-8. PubMed ID: 25960225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.